Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-25 @ 3:39 AM
NCT ID:
NCT06092502
Eligibility Criteria:
Inclusion Criteria:
* 20-50 years of age with complaints of shoulder pain in the anterio-lateral region lasting more than 6 weeks, with a positive Neer impingement test and/or a positive Hawkins-Kennedy test
* Additionally, patients must have at least one of the symptoms listed. These symptoms are: painful arch on active shoulder elevation, pain with resisted shoulder external rotation in abduction at 90°, and a positive empty can test.
Exclusion Criteria:
* Having had a steroid injection into the shoulder within the last 3 months
* Previous surgery on the neck, thoracic spine or shoulder
* Red flags (e.g. tumor, fracture, metabolic diseases, rheumatoid arthritis, osteoporosis, resting blood pressure greater than 140/90 mmHg, history of long-term steroid use)
* History of shoulder dislocation, subluxation, fracture, adhesive capsulitis, frozen shoulder, or cervical or thoracic surgery
* History of full-thickness rotator cuff tear
* History of cervical disc herniation in the last 6 weeks
* History of breast cancer on the involved side
* Isolated acromioclavicular joint pathology (i.e., pain directly localized over the acromioclavicular joint).
* Signs of cervical radiculopathy, radiculitis, or referred pain originating from the cervical spine
* Receiving treatment for shoulder pain in the last 3 months
* Being currently pregnant (Dunning, 2022)
* Scoring ≤24 on the Standardized Mini Mental Test was determined.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
50 Years
Study:
NCT06092502
Study Brief:
Protocol Section:
NCT06092502